• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主遗传多样性和 SARS-CoV-2 的遗传变异在 COVID-19 发病机制和疫苗效力中的作用。

Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination.

机构信息

Department of Laboratory Sciences, School of Allied Medical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran.

Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Int Immunopharmacol. 2022 Oct;111:109128. doi: 10.1016/j.intimp.2022.109128. Epub 2022 Aug 8.

DOI:10.1016/j.intimp.2022.109128
PMID:35963158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9359488/
Abstract

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the outbreak of coronavirus disease 2019 (COVID-19), has shown a vast range of clinical manifestations from asymptomatic to life-threatening symptoms. To figure out the cause of this heterogeneity, studies demonstrated the trace of genetic diversities whether in the hosts or the virus itself. With this regard, this review provides a comprehensive overview of how host genetic such as those related to the entry of the virus, the immune-related genes, gender-related genes, disease-related genes, and also host epigenetic could influence the severity of COVID-19. Besides, the mutations in the genome of SARS-CoV-2 leading to emerging of new variants per se affect the affinity of the virus to the host cells and enhance the immune escape capacity. The current review discusses these variants and also the latest data about vaccination effectiveness facing the most important variants.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是导致 2019 年冠状病毒病(COVID-19)爆发的病原体,其临床表现从无症状到危及生命的症状不等。为了找出这种异质性的原因,研究表明宿主或病毒本身都存在遗传多样性的痕迹。有鉴于此,本综述全面概述了宿主遗传因素(如与病毒进入相关的基因、免疫相关基因、性别相关基因、疾病相关基因)以及宿主表观遗传因素如何影响 COVID-19 的严重程度。此外,SARS-CoV-2 基因组中的突变导致新变体的出现本身会影响病毒对宿主细胞的亲和力,并增强免疫逃逸能力。本综述讨论了这些变体以及面对最重要变体时疫苗有效性的最新数据。

相似文献

1
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination.宿主遗传多样性和 SARS-CoV-2 的遗传变异在 COVID-19 发病机制和疫苗效力中的作用。
Int Immunopharmacol. 2022 Oct;111:109128. doi: 10.1016/j.intimp.2022.109128. Epub 2022 Aug 8.
2
SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity.SARS-CoV-2 进入相关的病毒和宿主遗传变异:对 COVID-19 严重程度、免疫逃避和传染性的影响。
Int J Mol Sci. 2021 Mar 17;22(6):3060. doi: 10.3390/ijms22063060.
3
Genetic and epigenetic factors associated with increased severity of Covid-19.与 COVID-19 严重程度增加相关的遗传和表观遗传因素。
Cell Biol Int. 2021 Jun;45(6):1158-1174. doi: 10.1002/cbin.11572. Epub 2021 Mar 1.
4
Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.病毒和宿主之间的进化军备竞赛驱动了蝙蝠严重急性呼吸综合征相关冠状病毒刺突基因的遗传多样性。
J Virol. 2020 Sep 29;94(20). doi: 10.1128/JVI.00902-20.
5
Variants in ACE2; potential influences on virus infection and COVID-19 severity.ACE2 基因变异;对病毒感染和 COVID-19 严重程度的潜在影响。
Infect Genet Evol. 2021 Jun;90:104773. doi: 10.1016/j.meegid.2021.104773. Epub 2021 Feb 17.
6
Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).新型冠状病毒(SARS-CoV-2)对血管紧张素转换酶2(ACE2)结构识别的遗传变异研究。
J Transl Med. 2020 Aug 24;18(1):321. doi: 10.1186/s12967-020-02486-7.
7
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.冠状病毒发病机制的分子基础:以比较基因组学方法研究行星健康,以预防 21 世纪的人畜共患病爆发。
OMICS. 2020 Nov;24(11):634-644. doi: 10.1089/omi.2020.0131. Epub 2020 Sep 16.
8
Genetic and Epigenetic Diversity of Protein Molecules Related to SARSCoV- 2 Entry: Where We Are and Where We Should Go?SARS-CoV-2 进入相关蛋白分子的遗传和表观遗传多样性:我们在哪里以及我们应该去哪里?
Curr Protein Pept Sci. 2022;23(2):70-76. doi: 10.2174/1389203723666220201160820.
9
Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19.遗传变异和基因表达在 COVID-19 的易感性和严重程度中的作用。
Ann Lab Med. 2021 Mar 1;41(2):129-138. doi: 10.3343/alm.2021.41.2.129.
10
Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.病毒受体ACE2直系同源物的功能和遗传分析揭示了SARS-CoV-2广泛的潜在宿主范围。
Proc Natl Acad Sci U S A. 2021 Mar 23;118(12). doi: 10.1073/pnas.2025373118.

引用本文的文献

1
The Possible Mechanistic Basis of Individual Susceptibility to Spike Protein Injury.个体对刺突蛋白损伤易感性的可能机制基础。
Adv Virol. 2025 Jun 24;2025:7990876. doi: 10.1155/av/7990876. eCollection 2025.
2
Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population.伊朗人群中 COVID-19 疫苗的免疫原性和不良反应在健康人群和自身免疫性疾病患者中的表现。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241239202. doi: 10.1177/03946320241239202.
3
Novel Mutations in the Non-Structure Protein 2 of SARS-CoV-2.

本文引用的文献

1
The role of high cholesterol in SARS-CoV-2 infectivity.高胆固醇在 SARS-CoV-2 感染性中的作用。
J Biol Chem. 2023 Jun;299(6):104763. doi: 10.1016/j.jbc.2023.104763. Epub 2023 Apr 28.
2
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.BNT162b2 疫苗对 5 至 11 岁儿童中奥密克戎的有效性。
N Engl J Med. 2022 Jul 21;387(3):227-236. doi: 10.1056/NEJMoa2205011. Epub 2022 Jun 29.
3
Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability.
新型冠状病毒非结构蛋白2中的新型突变
Mediterr J Hematol Infect Dis. 2023 Nov 1;15(1):e2023059. doi: 10.4084/MJHID.2023.059. eCollection 2023.
4
Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19.IFNL、HLA 和 IL-6 基因多态性变化对 COVID-19 重症病例的影响。
Exp Biol Med (Maywood). 2023 May;248(9):787-797. doi: 10.1177/15353702231181343. Epub 2023 Jul 15.
5
Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities.SARS-CoV-2 人类受体基因内的遗传变异可能导致不同种族的疾病结局存在差异。
Int J Mol Sci. 2023 May 13;24(10):8711. doi: 10.3390/ijms24108711.
6
Genetic Variants and Protective Immunity against SARS-CoV-2.遗传变异与对 SARS-CoV-2 的保护性免疫。
Genes (Basel). 2022 Dec 13;13(12):2355. doi: 10.3390/genes13122355.
7
SARS-CoV-2 variants: Impact on biological and clinical outcome.严重急性呼吸综合征冠状病毒2变体:对生物学和临床结果的影响。
Front Med (Lausanne). 2022 Nov 10;9:995960. doi: 10.3389/fmed.2022.995960. eCollection 2022.
8
Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings.基于配体的冠状病毒主蛋白酶抑制剂的发现使用 MACAW 分子嵌入。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):24-35. doi: 10.1080/14756366.2022.2132486.
关注的 SARS-CoV-2 变体之间的环境稳定性差异:奥密克戎 BA.1 和 BA.2 都具有更高的稳定性。
Clin Microbiol Infect. 2022 Nov;28(11):1486-1491. doi: 10.1016/j.cmi.2022.05.020. Epub 2022 May 28.
4
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.德尔塔刺突 P681R 突变增强了 SARS-CoV-2 对阿尔法变体的适应能力。
Cell Rep. 2022 May 17;39(7):110829. doi: 10.1016/j.celrep.2022.110829. Epub 2022 Apr 29.
5
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.同源和异源加强针对于灭活 SARS-CoV-2 疫苗的有效性:一项大规模前瞻性队列研究。
Lancet Glob Health. 2022 Jun;10(6):e798-e806. doi: 10.1016/S2214-109X(22)00112-7. Epub 2022 Apr 23.
6
Dichlorophenylpyridine-Based Molecules Inhibit Furin through an Induced-Fit Mechanism.基于二氯苯基吡啶的分子通过诱导契合机制抑制弗林蛋白酶。
ACS Chem Biol. 2022 Apr 15;17(4):816-821. doi: 10.1021/acschembio.2c00103. Epub 2022 Apr 4.
7
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.一种 TMPRSS2 抑制剂可作为泛 SARS-CoV-2 的预防和治疗药物。
Nature. 2022 May;605(7909):340-348. doi: 10.1038/s41586-022-04661-w. Epub 2022 Mar 28.
8
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.南非出现奥密克戎后,SARS-CoV-2 再感染的风险增加。
Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947.
9
Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants.新型 SARS-CoV-2 变体刺突蛋白的结构和抗原性变化。
PLoS Pathog. 2022 Feb 17;18(2):e1010260. doi: 10.1371/journal.ppat.1010260. eCollection 2022 Feb.
10
The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.B.1.427/1.429(ε)新型冠状病毒变种在叙利亚仓鼠中比原始的B.1(614G)毒株更具毒性。
PLoS Pathog. 2022 Feb 10;18(2):e1009914. doi: 10.1371/journal.ppat.1009914. eCollection 2022 Feb.